Patterson Cash Flow from Operating Activities 2010-2024 | PDCO

Patterson cash flow from operating activities from 2010 to 2024. Cash flow from operating activities can be defined as a company's cash flows from operations.
Patterson Annual Cash Flow Ops
(Millions of US $)
2023 $-755
2022 $-981
2021 $-731
2020 $-244
2019 $48
2018 $179
2017 $163
2016 $156
2015 $263
2014 $196
2013 $299
2012 $321
2011 $263
2010 $265
2009 $124
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $2.308B $6.471B
Patterson Companies Inc. is one of the leading distributors of dental and animal health products. It has 3 segments: Dental, Animal Health and Corporate. Dental segment distributes consumable products, basic & advanced technology dental equipment, practice management & clinical software, patient education systems, and office forms and stationery in the U.S. & Canada. Its customers include dentists, dental laboratories, institutions, and other healthcare professionals. This unit is also the exclusive distributor for Sirona Dental Systems, a leading dental technologies company. Animal Health unit is a leading distributor of veterinary supplies to companion-pet veterinary clinics, equine and large animal veterinary clinics, public and private institutions, and shelters across the U.S. It acquired Animal Health International. Corporate segment comprises general and administrative expenses, including home office support costs in areas such as information technology, finance, legal, human resources and facilities.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $73.379B 20.59
Becton Dickinson (BDX) United States $68.292B 19.32
West Pharmaceutical Services (WST) United States $25.906B 46.43
Cardinal Health (CAH) United States $24.133B 13.80
Align Technology (ALGN) United States $20.439B 39.46
Cooper (COO) United States $19.341B 29.27
Labcorp (LH) United States $17.753B 15.28
Henry Schein (HSIC) United States $9.553B 16.99
DENTSPLY SIRONA (XRAY) United States $5.872B 15.20
Merit Medical Systems (MMSI) United States $4.758B 26.08
CONMED (CNMD) United States $2.301B 20.87
STAAR Surgical (STAA) United States $2.098B 80.57
Atrion (ATRI) United States $0.819B 43.73
Lifevantage (LFVN) United States $0.086B 11.11
Pro-Dex (PDEX) United States $0.067B 33.62
Biolase (BIOL) United States $0.005B 0.00